🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
This randomized, double-blind, parallel group study compares the efficacy a...
Status
Completed
Location
Multiple Locations
Start Date
2010-09
Trial ID
NCT01194414
Overall the study investigates organ crosstalk during exercise. More specif...
Status
Completed
Location
Rigshospitalet
Start Date
2024-04-09
Trial ID
NCT06334653
Treatments Being Tested
The goal of this clinical trial is to investigate the immunomodulatory effe...
Status
Recruiting
Location
Intensive Care Medicine, Radboud University Nijmegen Medical Centre
Start Date
2024-10-24
Trial ID
NCT06624436
Treatments Being Tested
Giant-cell arteritis (GCA) is an immune-mediated disease that mostly affect...
Status
Completed
Location
Department of Rheumatology, Clinical Immunology Allergology, University Hospital, Inselspital
Start Date
2011-09
Trial ID
NCT01450137
Treatments Being Tested
A multicenter, randomized, double-blind, placebo-controlled, and active dru...
Status
Enrolling By Invitation
Location
Peking University People's Hospital
Start Date
2025-04-09
Trial ID
NCT06726096
Treatments Being Tested
Title: The use of Tocilizumab in the management of patients who have severe...
Status
Unknown
Location
Hadassah Medical Orginisation
Start Date
2020-04-08
Trial ID
NCT04377750
Treatments Being Tested
The purpose is to investigate tocilizumab administration in patients with m...
Status
Completed
Location
Hospital Clínico de Santiago
Start Date
2012-03
Trial ID
NCT01297699
Treatments Being Tested
The purpose of this research study is to see if a study drug called Tociliz...
Status
Completed
Location
Cedars Sinai Medical Center (CACS)
Start Date
2018-12-20
Trial ID
NCT03644667
Treatments Being Tested
Primary Objective: To assess, in the same study, the safety of sarilumab a...
Status
Completed
Location
Investigational Site Number 840152
Start Date
2013-03
Trial ID
NCT01768572
The aim of this clinical trial is to determine the efficacy of tocilizumab ...
Status
Not Yet Recruiting
Location
Groupe Hospitalier de l'Institut Catholique de Lille
Start Date
2026-04
Trial ID
NCT07254637
Treatments Being Tested